Written answers
Tuesday, 5 November 2024
Department of Health
Medicinal Products
Brendan Griffin (Kerry, Fine Gael)
Link to this: Individually | In context | Oireachtas source
1131. To ask the Minister for Health further to Parliamentary Question No. 752 of 22 October 2024, when the HSE will meet the manufacturer to reconsider the possible approval of the reimbursement of palforzia for the treatment of peanut allergy; and if he will make a statement on the matter. [44435/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments